Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
基本信息
- 批准号:10721752
- 负责人:
- 金额:$ 8.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-05 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAcidsAmericanAnalgesicsArthralgiaArthritisAttentionCartilageClinicalDegenerative polyarthritisDexamethasoneDiseaseEffectivenessFoundationsGoalsGrantHemorrhageHyaluronic AcidHydrogelsIn VitroInflammationInjectableIntra-Articular InjectionsJointsLidocaineLiquid substanceMentorsNatural regenerationNeedlesOralPainPenetrationPharmaceutical PreparationsPopulationResearchSolventsSteroidsStomachStudentsSupervisionTechniquesTherapeutic EffectTissuesUlcerUnderrepresented StudentsWorkarthropathiescareercartilage degradationcartilage regenerationchondroprotectiondesigndisabilitygraduate studentimprovedin vivojoint destructionlaurencinnon-opioid analgesicnovelosteoarthritis painpain reliefparent grantpreventside effectsynergism
项目摘要
Abstract
Millions of Americans suffer from arthritis (e.g., osteoarthritis or OA), a disease associated with inflammation that
causes pain and disability, especially in senior population. Current treatments that focus on alleviating
pain/inflammation in joints include steroids, non-steroid or non-opioids anti-inflammation drugs, and intra-
articular injection. However, these drugs have limitations and many side effects such as causing stomach
bleeding/ ulcers when taken orally. In the parent grant, we proposed an approach to use non-opioid analgesic
drugs with controlled sustain release obtained from microneedle technique for the treatment of OA pain and
inflammation. In this study, we would like to investigate another approach to manage OA pain through intra-
articular injection of a novel ionic liquid hydrogel. Hyaluronic acid (HA) intra-articular injection is commonly used
to clinically treat joint pain due to its unique ability to suppress anti-inflammation and chondroprotection.
Furthermore, when HA synergizes with other pain-relief drugs (e.g., Dexamethasone or DEX), the new
combination has a greater pain relief efficacy than HA alone.
Recently ionic liquid and deep eutectic solvents have gained a great attention because of their high stability and
effectiveness for higher drug loading capacity. The liquid also improves drug tissue penetration and can act as
drugs themselves (e.g. lidocaine). Our hypothesis is that hyaluronic acid grafted ionic liquid/ deep eutectic
solvents (e.g., Decanoic Acid-Lidocaine) would increase therapeutic effect to treat OA pain and inflammation
while preventing join degeneration both in vitro and in vivo. In this supplementary grant, we would have our
under-represented graduate student, Tra Vinikoor, research and improve OA therapy by using a HA-grafted ionic
liquid or deep eutectic solvent with dual functions of preventing joint degeneration and reducing inflammation.
The graduate student will perform the study under the support and supervision of the PI (Dr. Thanh Nguyen) and
the co-mentor (Dr. Cato Laurencin). This study will be very important to the student to continue her work on
injectable hydrogels for cartilage regeneration/OA treatment and lay a strong foundation for her to achieve her
long-term career goals in academia.
抽象的
数以百万计的美国人患有关节炎(例如骨关节炎或OA),这种疾病与炎症有关
引起疼痛和残疾,尤其是在老年人中。目前专注于减轻的治疗
关节中的疼痛/炎症包括类固醇,非类固醇或非阿片类药物抗炎药,以及内部
关节注射。但是,这些药物有局限性和许多副作用,例如引起胃
口服时出血/溃疡。在父母赠款中,我们提出了一种使用非阿片类镇痛药的方法
从微针技术获得的具有控制的维持释放的药物,用于治疗OA疼痛和
炎。在这项研究中,我们想调查另一种通过内部管理OA疼痛的方法
新型离子液体水凝胶的关节注射。通常使用透明质酸(HA)关节内注射
由于其独特的抑制抗炎和软骨保护的能力,因此可以在临床上治疗关节疼痛。
此外,当HA与其他止痛药协同(例如,地塞米松或dex)时,新的
组合比单独的HA具有更大的缓解疼痛功效。
最近,由于它们的稳定性高和
较高药物加载能力的有效性。液体还改善了药物组织的渗透,可以充当
毒品本身(例如利多卡因)。我们的假设是透明质酸接枝的离子液体/深晶
溶剂(例如,二烷酸 - 苯甲酸)将增加治疗作用以治疗OA疼痛和炎症
在防止体外和体内结合变性的同时。在这项补充赠款中,我们将拥有我们的
通过使用HA-GRAFT IONIC
液体或深层溶剂,具有预防关节变性和减少炎症的双重功能。
研究生将在PI的支持和监督下进行研究(Thanh Nguyen博士)和
联合学(Cato Laurencin博士)。这项研究对学生继续她的工作非常重要
用于软骨再生/OA处理的可注射水凝胶,为她奠定了坚实的基础
学术界的长期职业目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thanh Nguyen其他文献
Thanh Nguyen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thanh Nguyen', 18)}}的其他基金
Novel Piezoelectric Amino-acid Ultrasound Transducer to Deliver Drugs Through the Blood Brain Barrier
新型压电氨基酸超声换能器通过血脑屏障输送药物
- 批准号:
10636328 - 财政年份:2023
- 资助金额:
$ 8.31万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10618335 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Biodegradable Piezoelectric Nanocomposite Scaffold with Physical Exercise to Heal Major Cartilage Defects in Large Animals
可生物降解的压电纳米复合支架与体育锻炼可治愈大型动物的主要软骨缺陷
- 批准号:
10342706 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Biodegradable Piezoelectric Nanocomposite Scaffold with Physical Exercise to Heal Major Cartilage Defects in Large Animals
可生物降解的压电纳米复合支架与体育锻炼可治愈大型动物的主要软骨缺陷
- 批准号:
10634516 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Real-time Measurement of Joint-loading for Osteoarthritis Study and Treatment R21AR078744
用于骨关节炎研究和治疗的关节负荷实时测量 R21AR078744
- 批准号:
10362159 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Real-time measurement of joint-loading for osteoarthritis study and treatment
实时测量关节负荷,用于骨关节炎研究和治疗
- 批准号:
10359757 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Real-time measurement of joint-loading for osteoarthritis study and treatment
实时测量关节负荷,用于骨关节炎研究和治疗
- 批准号:
10566872 - 财政年份:2021
- 资助金额:
$ 8.31万 - 项目类别:
Biodegradable and Biocompatible Piezoelectric Nanofiber Mat for Wound Dressing
用于伤口敷料的可生物降解和生物相容性压电纳米纤维垫
- 批准号:
10046001 - 财政年份:2020
- 资助金额:
$ 8.31万 - 项目类别:
Biodegradable and Biocompatible Piezoelectric Nanofiber Mat for Wound Dressing
用于伤口敷料的可生物降解和生物相容性压电纳米纤维垫
- 批准号:
10220853 - 财政年份:2020
- 资助金额:
$ 8.31万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
一项饮食干预研究,旨在减轻患有急性后 COVID-19 综合症的老年人的疲劳症状并改善肌肉和身体功能
- 批准号:
10734981 - 财政年份:2023
- 资助金额:
$ 8.31万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10594005 - 财政年份:2022
- 资助金额:
$ 8.31万 - 项目类别:
Puipuia le Ola: Increasing reach and uptake of COVID-19 testing among Pacific Islanders in Hawaii and Guam
Puipuia le Ola:在夏威夷和关岛的太平洋岛民中扩大 COVID-19 检测的覆盖范围和接受度
- 批准号:
10259631 - 财政年份:2020
- 资助金额:
$ 8.31万 - 项目类别:
Protein palmitoylation in synuclein pathophysiology
突触核蛋白病理生理学中的蛋白质棕榈酰化
- 批准号:
9889191 - 财政年份:2019
- 资助金额:
$ 8.31万 - 项目类别: